Is Concord Medical Services Holdings Limited (CCM) a Buy, Sell, or Hold?
NYSE : CCM
Concord Medical Services Holdings Limited
$4.04 USD
-$0.23 (-5.39%)
- Volume
- 43.64K
- Average Volume
- 51K
- Market Capitalization
- $588.28K
- P/E Ratio
- -0.03
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.77
- Year Low
- $3.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.48
Company Overview
NYSE
Jianyu Yang
Medical - Care Facilities
Healthcare
CCM
610
CN
USD
Liquidity Metrics
-1.73
0.48
0.46
0.15
0.00
Sales & Valuation
$460.51M
0.01
0.00
0.00
0.00
Profitability
-$621
-$92.81M
-21.25%
-63.75%
5.73%
-1.90%
P/E Metrics
-0.03
0.00
0.00
Analyst Price Target & Rating
2/5
2 Analysts
%
Financial Health Scores
-1.19
6/9
-$1.01B
$6.55B
$4.7B
-$284.92M
Key Metrics (TTM)
$3.34B
5.70
-27.57
0.48
5.73%
-4.26%
-3149.52%
0.00%
-22 days
Company Executives
| Name | Title |
|---|---|
| Xun Liu | Financial Controller |
| Wei Jiang | Chief Financial Officer |
| Botao Shi | Interim Chief Financial Officer |
| Boxun Zhang | Chief Strategy Officer |
| Jianyu Yang | Chairman & Chief Executive Officer |
Poll Results
No votes yet today — be the first to share your view!
About Concord Medical Services Holdings Limited (NYSE:CCM) Stock
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors an ... d other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
2026-06-22 07:00:00
NEW YORK--(BUSINESS WIRE)--TWO Urges Stockholders to Vote FOR the CCM Transaction Today; Failure to Approve Risks a Significant Decline in TWO's Stock Price.
ComplianceCow to Demonstrate Generative AI-Powered CCM 3.0 Controls in ServiceNow IRM
2026-06-11 11:00:00
SAN FRANCISCO--(BUSINESS WIRE)--ComplianceCow, an agentic automation platform for enterprise security GRC teams, will host a live webinar on June 22, 2026 demonstrating how Generative AI transforms natural language inputs into deterministic, auditable Continuous Controls Monitoring (CCM) 3.0 controls inside ServiceNow IRM. The session, titled From Prompt to Production: Building Automated CCM 3.0 Controls with Generative AI in ServiceNow IRM, runs from 1:30 to 2:00 pm ET and is open to complianc.
2026-06-11 08:20:00
TYSONS, Va.--(BUSINESS WIRE)--RegScale, the AI-powered continuous controls monitoring (CCM) platform, today announced it has achieved ISO 27001 certification in under 30 days using its own Continuous Controls Monitoring (CCM) platform. For most organizations pursuing certification through manual processes, the journey runs around six months. RegScale's result demonstrates what becomes possible when compliance runs continuously: certification is a byproduct of the program, not a project of its o.
2026-05-13 09:05:00
Highlights: According to third-party industry reports, the U.S. RPM market is currently $14 Billion alone and expected to reach approximately $29 Billion by 2030, representing a 12.6% CAGR, as healthcare providers continue shifting toward value-based and home-based care models¹ Pilot initiative launched across multiple provider offices focused on chronic care management (CCM) and remote patient monitoring (RPM) through it's MSO infrastructure Approximately 1,500+ claims generated to date through the pilot infrastructure with expansion roadmap targeting additional providers Wellgistics Pharmacy Network of 6,500+ independent pharmacies positioned to support patient engagement and care coordination initiatives Participating pharmacists expected to gain access to new clinical service revenue opportunities TAMPA, FL / ACCESS Newswire / May 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced a pilot collaboration with Kare PharmTech and Kare Clinicals integrating its MSO infrastructure to support chronic care management ("CCM") and remote patient monitoring ("RPM") services across participating provider offices. According to third-party industry reports, the U.S. RPM market is currently $14 Billion and expected to reach approximately $29 Billion by 2030, representing a 12.6% CAGR, as healthcare providers continue shifting toward value-based and home-based care models.
Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025
2026-04-29 07:06:00
BEIJING, April 29, 2026 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the "Annual Report") with the U.S. Securities and Exchange Commission ("SEC"). An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov.
Frequently Asked Questions
-
What is the current Concord Medical Services Holdings Limited (CCM) stock price?
-
Concord Medical Services Holdings Limited(NYSE:CCM) stock price is $4.04 in the last trading session. During the trading session, CCM stock reached the peak price of $10.77 while $3.18 was the lowest point it dropped to. The percentage change in CCM stock occurred in the recent session was --5.39% while the dollar amount for the price change in CCM stock was -$0.23.
-
CCM's industry and sector of operation?
-
The NYSE listed CCM is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
-
Who are the executives of CCM?
-
Xun Liu | Financial Controller
Wei Jiang | Chief Financial Officer
Botao Shi | Interim Chief Financial Officer
Boxun Zhang | Chief Strategy Officer
Jianyu Yang | Chairman & Chief Executive Officer -
How many employees does CCM have?
-
Number of CCM employees currently stands at 610. CCM operates from East Zone, Hanwei Plaza, Beijing, NY 100020, CN.
-
Link for CCM official website?
-
Official Website of CCM is: https://ir.ccm.cn
-
How do I contact CCM?
-
CCM could be contacted at phone #86 10 5903 6688 and can also be accessed through its website. CCM operates from East Zone, Hanwei Plaza, Beijing, NY 100020, CN.
-
How many shares of CCM are traded daily?
-
The average number of CCM shares traded daily for last 3 months was 51K.
-
What is the market cap of CCM currently?
-
The market value of CCM currently stands at $588.28K with its latest stock price at $4.04